에임드바이오
Not investment advice · For research purposes only; not a solicitation or an offer of any financial product. Past statistics do not indicate future outcomes. Facts from filings and public sources; not investment advice. No valuation estimate, direction or trading levels are provided.
① Fact table
Values as filed · consolidated / separate basis per year · no interpretation
| Item | 2025 | Unit |
|---|---|---|
| Revenue | KRW 47.3bn | KRW |
| Operating income | KRW 20.8bn | KRW |
| Net income | KRW 5.0bn | KRW |
| Total equity | KRW 192.6bn | KRW |
| Total liabilities | KRW 6.4bn | KRW |
| 부채비율(자체 계산: 부채총계 ÷ 자본총계 × 100, 자본 0 이하면 비움, 같은 해 같은 기준)· in house | 3.32 | % |
| Statement basis | Consolidated |
Show raw values
| Item | 2025 | Unit |
|---|---|---|
| Revenue | 47,278,353,425 | KRW |
| Operating income | 20,768,575,294 | KRW |
| Net income | 5,022,565,524 | KRW |
| Total equity | 192,568,800,976 | KRW |
| Total liabilities | 6,396,747,607 | KRW |
| 부채비율(자체 계산: 부채총계 ÷ 자본총계 × 100, 자본 0 이하면 비움, 같은 해 같은 기준) | 3.32 | % |
Source: dart_fnltt · Computed in house · card as of 2026-10-13 · Filing date per year: not on the card (see the filing timeline below) · 'in house' marks items computed from the values above
② Profitability breakdown
Arithmetic on the fact table only · same year, same basis · '—' where a value is missing or the denominator is 0 or below · in each panel the bar height maps the span from the most negative to the largest positive value onto the panel height · no interpretation attached
Source: computed in house from the fact table · card as of 2026-10-13
③ My own calculation
A simple residual-income formula. You enter the assumptions; only the base equity is filled in from the filing. The result is computed from your assumptions and is not a figure this site publishes.
V = B₀ + (ROE − r) × B₀ ÷ (1 + r − ω)
Fill in all four boxes to compute. The site fills in nothing but the base equity.
Computed in this browser only; nothing you type is sent or stored.
- 2026-09-22Filing title as filed[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인) original ↗Source: dart_disclosure
- 2026-09-18Filing title as filed임원ㆍ주요주주특정증권등소유상황보고서 original ↗Source: dart_disclosure
- 2026-09-02Filing title as filed[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인) original ↗Source: dart_disclosure
- 2026-08-21Filing title as filed[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인) original ↗Source: dart_disclosure
- 2026-08-18Filing title as filed[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인) original ↗Source: dart_disclosure
- 2026-08-12Filing title as filed반기보고서 (2026.06) original ↗Source: dart_disclosure
- 2026-08-10Filing title as filed[기재정정]투자판단관련주요경영사항(임상시험계획승인신청) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청) original ↗Source: dart_disclosure
- 2026-07-22Filing title as filed[기재정정]투자판단관련주요경영사항(임상시험계획승인신청) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청) original ↗Source: dart_disclosure
- 2026-07-16Filing title as filed임시주주총회결과 original ↗Source: dart_disclosure
- 2026-07-16Filing title as filed독립이사의선임ㆍ해임또는중도퇴임에관한신고 original ↗Source: dart_disclosure
- 2026-07-15Filing title as filed[기재정정]투자판단관련주요경영사항(임상시험계획승인신청) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청) original ↗Source: dart_disclosure
- 2026-07-01Filing title as filed주주총회소집공고 original ↗Source: dart_disclosure
- 2026-06-30Filing title as filed기업설명회(IR)개최 original ↗Source: dart_disclosure
- 2026-06-26Filing title as filed투자판단관련주요경영사항 (ODS025 기술이전계약 관련 마일스톤 기술료 수령) original ↗Source: dart_disclosure
- 2026-06-26Filing title as filed투자판단관련주요경영사항(임상시험계획승인신청등결정) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인) original ↗Source: dart_disclosure
- 2026-06-16Filing title as filed[기재정정]투자판단관련주요경영사항(임상시험계획승인신청) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청) original ↗Source: dart_disclosure
- 2026-06-05Filing title as filed주주명부폐쇄기간또는기준일설정 original ↗Source: dart_disclosure
- 2026-06-05Filing title as filed주주총회소집결의 (임시주주총회) original ↗Source: dart_disclosure
- 2026-05-27Filing title as filed투자판단관련주요경영사항(임상시험계획승인신청) original ↗Source: dart_disclosure
- 2026-05-15Filing title as filed[기재정정]분기보고서 (2026.03) original ↗Source: dart_disclosure
| Layer | Badge | n | Note |
|---|---|---|---|
| range | unknown | 0 | 80%·90% 범위의 전향 적중 기록(목표일 개장 전 박제 → 종가 공표 뒤 채점) |
| fair_value | 제공 안 함 | 0 | 판별력 미확인 — 싣지 않음 |
| direction | 제공 안 함 | 0 | 판별력 미확인 — 싣지 않음 |
| trade_levels | 제공 안 함 | 0 | 판별력 미확인 — 싣지 않음 |
| Valuation estimate | not provided | — | Not published: no demonstrated discriminative power |
| Direction (up or down) | not provided | — | Not published: no demonstrated discriminative power |
| Trading levels | not provided | — | Not published: no demonstrated discriminative power |
Why this?
Checking…